Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Aug 17:6:31727.
doi: 10.1038/srep31727.

Serum pharmacodynamic biomarkers for chronic corticosteroid treatment of children

Affiliations

Serum pharmacodynamic biomarkers for chronic corticosteroid treatment of children

Yetrib Hathout et al. Sci Rep. .

Abstract

Corticosteroids are extensively used in pediatrics, yet the burden of side effects is significant. Availability of a simple, fast, and reliable biochemical read out of steroidal drug pharmacodynamics could enable a rapid and objective assessment of safety and efficacy of corticosteroids and aid development of corticosteroid replacement drugs. To identify potential corticosteroid responsive biomarkers we performed proteome profiling of serum samples from DMD and IBD patients with and without corticosteroid treatment using SOMAscan aptamer panel testing 1,129 proteins in <0.1 cc of sera. Ten pro-inflammatory proteins were elevated in untreated patients and suppressed by corticosteroids (MMP12, IL22RA2, CCL22, IGFBP2, FCER2, LY9, ITGa1/b1, LTa1/b2, ANGPT2 and FGG). These are candidate biomarkers for anti-inflammatory efficacy of corticosteroids. Known safety concerns were validated, including elevated non-fasting insulin (insulin resistance), and elevated angiotensinogen (salt retention). These were extended by new candidates for metabolism disturbances (leptin, afamin), stunting of growth (growth hormone binding protein), and connective tissue remodeling (MMP3). Significant suppression of multiple adrenal steroid hormones was also seen in treated children (reductions of 17-hydroxyprogesterone, corticosterone, 11-deoxycortisol and testosterone). A panel of new pharmacodynamic biomarkers for corticosteroids in children was defined. Future studies will need to bridge specific biomarkers to mechanism of drug action, and specific clinical outcomes.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Corticosteroid-responsive serum protein biomarkers in children with DMD.
Shown are SOMAscan analyses of cross-sectional groups of corticosteroid-naïve children (DMD; n = 9), corticosteroid-treated children (DMD + CS; n = 5), and healthy children (CT; n = 4). ITGa1/b1: Integrin alpha-I/beta-1 complex. IL22RA2: interleukin-22 receptor subunit alpha2; MMP12: matrix metalloproteinase 12 also known as macrophage metalloelastase; MMP3: matrix metalloproteinase 3 also known as stromelysin 1. Values for each protein are plotted as RFU (relative fluorescent units) and represent the average mean and standard error in each group.
Figure 2
Figure 2. Correlation of SOMAscan and ELISA assays for corticosteroid-responsive proteins.
Serum samples from DMD boys were tested in parallel by the two methods, and values plotted. The number of samples tested was different from protein to protein due the availability of serum samples.
Figure 3
Figure 3. Adrenal steroidal hormones are suppressed by chronic corticosteroid treatment in DMD and IBD children.
(a) Longitudinal analysis of DMD children (n = 9) and age-matched controls (n = 4). (b) Longitudinal analysis of IBD children (n = 11). Values for steroids are plotted in ng/mL and represent the average mean and standard error in each group.

Similar articles

Cited by

References

    1. Hillier S. G. Diamonds are forever: the cortisone legacy. The Journal of endocrinology 195, 1–6 (2007). - PubMed
    1. Swartz S. L. & Dluhy R. G. Corticosteroids: clinical pharmacology and therapeutic use. Drugs 16, 238–255 (1978). - PubMed
    1. Kapadia C. R. et al.. Endocrine Effects of Inhaled Corticosteroids in Children. JAMA Pediatr 170, 163–170 (2016). - PubMed
    1. Liu D. et al.. A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy Asthma Clin Immunol 9, 30 (2013). - PMC - PubMed
    1. von Scheven E., Corbin K. J., Stagi S. & Cimaz R. Glucocorticoid-associated osteoporosis in chronic inflammatory diseases: epidemiology, mechanisms, diagnosis, and treatment. Curr Osteoporos Rep 12, 289–299 (2014). - PubMed

Publication types

MeSH terms